Document ID: chunk:federal_register_of_legislation:F2025L00083:front:0:p1
Version: federal_register_of_legislation:F2025L00083
Segment Type: other
Provision Reference: 
Character Range: 0–3339

National Health (Continued Dispensing – Emergency Measure) Determination 2025

PB 12 of 2025

I, Rebecca Richardson, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated 4 February 2025

Rebecca Richardson
Assistant Secretary
Pricing and PBS Policy
Technology Assessment and Access Division
Department of Health and Aged Care

Contents
Part 1—Preliminary
1.01  Name
1.02  Commencement
1.03  Authority
1.04  Schedules
1.05  Definitions
1.06  Purpose
1.07  Operation of this instrument
Part 2—Pharmaceutical benefits that may be supplied without a prescription
2.01  Pharmaceutical benefits covered by this instrument
Part 3—Specified conditions for supplying pharmaceutical benefits without a prescription
3.01  General
3.02  Condition—unable to obtain prescription
3.03  Condition—previous supply of pharmaceutical benefit
3.04  Condition—stability of therapy
3.05  Condition—prior clinical review by PBS prescriber
3.06  Condition—prescription for last supply of pharmaceutical benefit
3.07  Condition—no continued dispensing in previous 12 months
3.08  Condition—declaration for supply of pharmaceutical benefit
3.09  Condition—maximum quantity of supply
3.10  Condition—preparing and recording information
Schedule 1—Pharmaceutical benefits that may be supplied without a prescription – pharmaceutical benefits that have certain listed drugs
Schedule 2—Repeals
National Health (Continued Dispensing – Emergency Measure) 2025

Part 1—Preliminary

1.01  Name
        1.    This instrument is the National Health (Continued Dispensing – Emergency Measure) Determination 2025.
        2.    This instrument may also be cited as PB 12 of 2025.

1.02  Commencement
        1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1                          Column 2                                          Column 3
Provisions                        Commencement                                      Date/Details
1.  Parts 1 to 3 and Schedule 1   Immediately after this instrument is registered.
2.  Schedule 2                    At the end of 31 March 2025

              Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
        1.     Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

1.03  Authority
  This instrument is made under subsection 89A(3) of the National Health Act 1953.

1.04  Schedules
  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

1.05  Definitions
        1.     In this instrument:
Act means the National Health Act 1953.

       electronic prescription has the meaning given by subsection 5(1) of the National Health (Pharmaceutical Benefits) Regulations 2017.

       increased maximum quantity of a